genedrive plc (AIM: GDR)

Market Cap	12.22M
Revenue (ttm)	272.00K
Net Income (ttm)	-5.00M
Shares Out	543.14M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,334,446
Open	2.260
Previous Close	2.250
Day's Range	2.111 - 2.260
52-Week Range	1.208 - 13.500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About genedrive

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid g...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: GDR

Financial Performance

In 2023, genedrive's revenue was 55,000, an increase of 12.24% compared to the previous year's 49,000. Losses were -5.15 million, 10.2% more than in 2022.